14-day Premium Trial Subscription Try For FreeTry Free
11.84€
-1.04 (-8.07%)
At Close: Jun 14, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions Profile
There is currently no insider trading information for this ticker.

However, we invite you to learn more about this term and how to use this knowledge to benefit your trading strategy:
Click to get the best stock tips daily for free!

About ABIVAX Société Anonyme

ABIVAX Société Anonyme ABIVAX Société Anonyme discovers and optimizes drugs for the treatment of inflammatory diseases, infectious diseases, and cancer in France. Its principal products include ABX464 that is in Phase IIb clinical trials for the treatment of ulcerative colitis and Crohn's Disease, as well as for COVID-19; Phase IIa clinical trial for the treatment of rheumatoid arthritis diseases; and has completed Phase IIa clinical trial for the treatment of viral ... ABVX.PA Profile

Golden Star

Ticker Date Change Price
LIN Jun 12 0.640% $434.17
BNDX Jun 12 0.637% $48.64
MAIN Jun 12 0.673% $49.01
EQR Jun 11 1.77% $65.55
RPM Jun 11 0.92% $110.28
FR Jun 11 1.52% $46.78
CAH Jun 11 1.20% $99.01
ESI Jun 11 11.50% $23.73
FTGC Jun 11 0.374% $24.09
FTSM Jun 11 0.0838% $59.68
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT